Home

Peter-Tompa
Prof. Peter Tompa

Prof. Peter Tompa

Short CV

  • Group leader at VIB and professor at VUB, since 2011
  • Director of VIB-VUB CSB, 2011-2015
  • Deputy director of Inst. Enzymology, Hungary, 2007-2009
  • Group leader at Inst. Enzymology, Hungary, 2006-2011
  • D.Sc. Hungarian Academy of Sciences, Budapest, Hungary, 2006
  • Postdoc in ECUST Uni. (China) - Weizmann Inst. (Israel) - St. Jude Children's Hosp. (US) - Tokyo Uni. (Japan)

Our team

Principal investigator: Peter Tompa
Postdoctoral researchers / subgroup leaders: Tamás Lázár, Junaid Ahmed, Joris Van Lindt
PhD researchers: Attila Mészáros, Kevin Muwonge, Giorgio Russo, Fernando Durán Armenta, Nazanin Farahi
Co-superivised PhD researchers: Margot Van Nerom, Rob Geens
Research assistants / Master students: Filipe Da Silva Lopes Amaral, Bedri Batuhan Yaman, Evagelos Efremidis
Lab manager: Mark Lackey

Research focus in brief

The study of structural disorder has already progressed way beyond simply establishing the disordered status of a protein. The current idea is that detailed experimental and theoretical characterization of the structural ensemble of disordered proteins in isolation, their structure in complex with their physiological partner(s), and the thermodynamics and kinetics of their interactions with their partners, whether stable (like in complexes) or fuzzy and transient (like in phase-separated bodies), hold the key to understanding these proteins and extending the structure–function paradigm to the disordered state. In this spirit, we undertake three different lines of research to push the frontiers of the field of structural disorder. Our studies have shown that structural disorder is prevalent in eukaryotic proteomes, disordered proteins carry out unique functions and they play important roles in serious diseases, such as cancer and neurodegeneration.

Recently, the focus of the lab turned to understanding the role of structural disorder in liquid-liquid phase separation (LLPS) of proteins in cell physiology and disease, with a primary focus on amyotrophic lateral sclerosis (ALS).

Sub-groups of the Tompa lab

Experimental characterization of IDPs driving diseases and biomolecular condensation
led by Peter Tompa
current members: Junaid Ahmed, Joris Van Lindt, Attila Meszaros, Kevin Muwonge, Giorgio Russo, Fernando Durán Armenta, Margot Van Nerom, Rob Geens, Filipe Da Silva Lopes Amaral, Bedri Batuhan Yaman

Bio- and chemoinformatics analysis and computational modeling of proteins and protein complexes
led by Tamás Lázár
current members: Nazanin Farahi, Evagelos Efremidis, Álvaro Navarro (visiting), Galo E. Balatti (visiting)

 

Applied experimental and computational techniques

  • Cloning / Protein expression / Protein purification
  • Absorbance measurements / Microscopy / FRAP
  • BLI / MST / ITC
  • DLS / SAXS
  • CD / NMR / X-ray crystallography
     
  • Structure prediction / Docking / MD / Macromolecular modeling
  • Chemoinformatics analysis of HTS data / QSAR modeling
  • Systems biology data integration / Short linear peptide motif analysis
  • Explorative analysis of biodata including clustering and machine learning

Consortia

Besides our own research projects, our lab is member of several large consortium projects and international collaborations.

PhasAGE

PhasAGE

Excellence Hub on Phase Transitions in Aging and Age-Related Disorders

Age-related diseases such as cancer and neurodegenerative disorders have become a public concern in Europe today due to the ageing population. The field of molecular biology is very promising for shedding light on late-onset diseases with a focus on incapacitating, age-related conditions. Portugal’s Instituto de Biologia Molecular e Celular (IBMC/i3S) has attracted international attention for its work in this domain. However, its scientists need to increase their competitivity in systems biology, bioinformatics and advanced biophysics. The EU-funded PhasAGE project will organise practical courses at the IBMC/i3S to offer the available knowledge in the field of phase transitions in ageing and age-related disorders. A unique collaborative network will be established between the IBMC/i3S, the Universities of Padua and Barcelona and the Vlaams Instituut voor Biotechnologie. Moreover, a European excellence hub will contribute to research and teaching quality.

COST

Non-globular proteins in the era of machine learning

COST ACTION CA21160 - Non-globular proteins in the era of machine learning (ML4NGP) aims to establish an interdisciplinary pan-European network to favour this interplay, fostering experimental frameworks designed to provide information to computational methods, and novel computational methods developed, trained and benchmarked with experimental data. ML4NGP will enhance the primary experimental data generation, promote integrative structural biology approaches, benchmark the state-of-the-art ML methods and improve the functional characterization of NGPs. The Action will support its scientific objectives through policies that sustain free knowledge exchange, inclusiveness and training of young researchers who will lead future innovations in this field.

Elixir

ELIXIR - IDP Community

The major goal of ELIXIR's IDP Community is to support the development of standards, tools and resources to accelerate the identification, analysis and functional characterisation of IDPs. Given their therapeutic relevance, IDR-mediated interactions are now seen as potential drug targets. A better understanding of their structure and function will help in developing new strategies to treat human diseases.

VUB

Dynamics of biocondensates

The project entitled "Optical and microfluidic tools to unravel the dynamics of bio-condensates" was funded by the VUB Spearhead programme in the Strategic Research Project (SRP) category.
Building on our prior experience with an SRP Growth funding project, we plan to combine state-of-the-art microfluidic approaches and optical detection for studying the phenomenon of biological condensation. We aim to develop novel chip designs for i) manipulating and visualizing sub- μ m particles, ii) creating special mixing regimes for studying equilibrium transient phenomena, and iii) observing nucleation phenomena on the surface or within droplets. These tools will help us to gain fundamental insight into the formation and evolution of liquid condensates and aggregates of proteins (e.g. TDP-43, hnRNP A2) related to amyotrophic lateral sclerosis (ALS) at the single-particle level. The synergy arising from this multidisciplinary approach will have a broad impact on various application domains. Not only will it provide a better understanding of the phenomenon of phase separation creating membraneless organelles (MLOs) in biology, it will also result in the development of generic microfluidic tools that can be used in studying a broad range of chemical and biological problems. Further, given the biomedical relevance of the molecular transitions under study, the novel insight will also foster the development of novel therapeutic approaches for treating age-related disorders.
The consortium is made up of four VUB groups, of Prof. Wim De Malsche, Prof. Heidi Ottevaere, Prof. Dominique Maes and Prof. Peter Tompa.

IDPfun

IDPfun (running out in 2023)

Driving the functional characterization of intrinsically disordered proteins

IDPfun is an international consortium aiming to extend our knowledge on the functions of IDPs. Starting from available state of the art computational tools and databases, which have been mostly developed by IDPfun participants, it aims drive a new level of IDP characterization leverage the complementary expertise of 5 EU MS and 3 TC institutions in Argentina, the latter providing useful complementary expertises. IDPfun will create a collaborative environment for research on novel ways to detect and characterize different IDP phenomena in their evolutionary context. It will develop an ontology and classification facilitating the comprehension of IDP complexity and aims to understand IDP functional mechanisms. The gained knowledge will be translated into major international protein databases for the benefit of the wider scientific community. Periodic meetings and symposia will generate a continuous knowledge exchange to be disseminated by open training schools and conferences. IDPfun will foster particularly young researchers, through dedicated activities and by ensuring adherence to the highest quality, ethics and gender balance standards. It is expected that IDPfun will strengthen overseas collaborations, focusing and coordinating research, leading to the creation of a sustainable international IDP community, driving knowledge and infrastructure in bioinformatics.